Marshall Kaplan

2.7k total citations · 1 hit paper
33 papers, 2.1k citations indexed

About

Marshall Kaplan is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Marshall Kaplan has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 20 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Marshall Kaplan's work include Liver Diseases and Immunity (20 papers), Liver Disease Diagnosis and Treatment (17 papers) and Liver Disease and Transplantation (8 papers). Marshall Kaplan is often cited by papers focused on Liver Diseases and Immunity (20 papers), Liver Disease Diagnosis and Treatment (17 papers) and Liver Disease and Transplantation (8 papers). Marshall Kaplan collaborates with scholars based in United States, Australia and Japan. Marshall Kaplan's co-authors include Eric M. Gershwin, Jenny Heathcote, Nora V. Bergasa, Keith D. Lindor, Raoul Poupon, Ross L. Coppel, Aftab A. Ansari, Judy Van de Water, M. Eric Gershwin and Hiroto Kita and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Gastroenterology.

In The Last Decade

Marshall Kaplan

32 papers receiving 2.0k citations

Hit Papers

Primary biliary cirrhosis # † 2009 2026 2014 2020 2009 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Primary biliary cirrhosis # †
    2009 809 citations Keith D. Lindor, Eric M. Gershwin et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marshall Kaplan United States 19 1.5k 1.2k 707 369 277 33 2.1k
Catherine Johanet France 28 1.6k 1.1× 1.5k 1.2× 733 1.0× 315 0.9× 614 2.2× 105 2.5k
Paolo Muratori Italy 33 2.1k 1.3× 2.0k 1.7× 854 1.2× 232 0.6× 633 2.3× 76 2.7k
Daniela Zauli Italy 26 1.1k 0.7× 1.0k 0.8× 292 0.4× 175 0.5× 456 1.6× 63 1.8k
F. Cassani Italy 36 2.4k 1.5× 2.2k 1.8× 682 1.0× 181 0.5× 881 3.2× 72 3.0k
Harlan I. Wright United States 17 856 0.6× 766 0.6× 532 0.8× 97 0.3× 78 0.3× 24 1.4k
J Larrauri Spain 19 434 0.3× 436 0.4× 679 1.0× 120 0.3× 276 1.0× 59 1.5k
Allister J. Grant United Kingdom 7 561 0.4× 375 0.3× 252 0.4× 432 1.2× 78 0.3× 8 1.1k
V. Desmet Belgium 20 655 0.4× 525 0.4× 509 0.7× 112 0.3× 68 0.2× 40 1.4k
Bárbara Torres Italy 13 1.1k 0.7× 1.0k 0.8× 397 0.6× 85 0.2× 262 0.9× 37 1.6k
Goroku Ohta Japan 24 614 0.4× 559 0.5× 883 1.2× 96 0.3× 164 0.6× 103 1.9k

Countries citing papers authored by Marshall Kaplan

Since Specialization
Citations

This map shows the geographic impact of Marshall Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marshall Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marshall Kaplan more than expected).

Fields of papers citing papers by Marshall Kaplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marshall Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marshall Kaplan. The network helps show where Marshall Kaplan may publish in the future.

Co-authorship network of co-authors of Marshall Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Marshall Kaplan. A scholar is included among the top collaborators of Marshall Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marshall Kaplan. Marshall Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jin‐Jun, Guoxiang Yang, Thomas P. Kenny, et al.. (2012). Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology. 57(4). 1498–1508. 51 indexed citations
2.
Lindor, Keith D., Eric M. Gershwin, Raoul Poupon, et al.. (2009). Primary biliary cirrhosis # †. Hepatology. 50(1). 291–308. 809 indexed citations breakdown →
3.
Kikuchi, Kentaro, Zhe‐Xiong Lian, Guoxiang Yang, et al.. (2005). Bacterial CpG induces hyper-IgM production in CD27+ memory B cells in primary biliary cirrhosis. Gastroenterology. 128(2). 304–312. 103 indexed citations
4.
Kita, Hiroto, Aftab A. Ansari, Xiaosong He, et al.. (2003). Proteasome is required for class I-restricted presentation by Fcγ receptor-mediated endocytosis in primary biliary cirrhosis. Journal of Autoimmunity. 21(2). 175–182. 8 indexed citations
5.
Kita, Hiroto, Zhe‐Xiong Lian, Judy Van de Water, et al.. (2002). Identification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis. The Journal of Experimental Medicine. 195(1). 113–123. 229 indexed citations
6.
Kita, Hiroto, Olga V. Naidenko, Mitchell Kronenberg, et al.. (2002). Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology. 123(4). 1031–1043. 182 indexed citations
7.
Matsumura, Shuji, Hiroto Kita, Xiaosong He, et al.. (2002). Comprehensive mapping of HLA-A*0201-restricted CD8 T-cell epitopes on PDC-E2 in primary biliary cirrhosis. Hepatology. 36(5). 1125–1134. 40 indexed citations
8.
Kaplan, Marshall. (1997). The Use of Methotrexate, Colchicine, and Other Immunomodulatory Drugs in the Treatment of Primary Biliary Cirrhosis. Seminars in Liver Disease. 17(2). 129–136. 21 indexed citations
9.
Gur, Hanan, Noori Barka, James B. Peter, et al.. (1995). Autoantibody Profile of Primary Sclerosing Cholangitis. Pathobiology. 63(2). 76–82. 22 indexed citations
10.
Zurgil, Neomi, Ronit Bakimer, Marshall Kaplan, Pierre Youinou, & Yehuda Shoenfeld. (1991). Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis. Journal of Clinical Immunology. 11(5). 239–245. 23 indexed citations
11.
Newman, Joel S., Elizabeth Oates, Sanjeev Arora, & Marshall Kaplan. (1991). Focal spared area in fatty liver simulating a mass. Digestive Diseases and Sciences. 36(7). 1019–1022. 1 indexed citations
12.
Kaplan, Marshall. (1991). Medical Approaches to Primary Sclerosing Cholangitis. Seminars in Liver Disease. 11(1). 56–63. 29 indexed citations
13.
Fregeau, David R., Thomas Prindiville, Ross L. Coppel, et al.. (1990). Inhibition of α–Ketoglutarate Dehydrogenase Activity by A Distinct Population of Autoantibodies Recognizing Dihydrolipoamide Succinyltransferase in Primary Biliary Cirrhosis. Hepatology. 11(6). 975–981. 58 indexed citations
14.
Kaplan, Marshall. (1989). Medical Treatment of Primary Biliary Cirrhosis. Seminars in Liver Disease. 9(2). 138–143. 20 indexed citations
15.
Kopelman, Richard I., et al.. (1988). Hypereosinophilic syndrome. Digestive Diseases and Sciences. 33(2). 233–239. 31 indexed citations
16.
Hou, Susan, et al.. (1984). Acute fatty liver of pregnancy. Digestive Diseases and Sciences. 29(5). 449–452. 20 indexed citations
17.
Kaplan, Marshall, et al.. (1983). Successful treatment of neonatal Flavobacterium meningosepticum infection. European Journal of Pediatrics. 140(4). 337–338. 7 indexed citations
18.
Larrègue, M, et al.. (1972). [Familial lymphohistiocytosis associated with lymphocytic meningitis].. PubMed. 28(7). 757–62. 1 indexed citations
19.
Kaplan, Marshall, et al.. (1960). [Infectious jaundice during infections with gram-negative bacilli in newborn and other infants].. PubMed. 36. 151–6. 1 indexed citations
20.
Kaplan, Marshall, et al.. (1957). [Hereditary episodic adynamia, particular form of familial periodic paralysis with hypercalcemia; first cases in France].. PubMed. 65(56). 1305–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine Johanet Breakdown of academic impact, for papers by Paolo Muratori Breakdown of academic impact, for papers by Daniela Zauli Breakdown of academic impact, for papers by F. Cassani Breakdown of academic impact, for papers by Harlan I. Wright Breakdown of academic impact, for papers by J Larrauri Breakdown of academic impact, for papers by Allister J. Grant Breakdown of academic impact, for papers by V. Desmet Breakdown of academic impact, for papers by Bárbara Torres Breakdown of academic impact, for papers by Goroku Ohta
Rankless by CCL
2026